Sandy Spring Bank’s Novavax NVAX Stock Holding History

Sandy Spring Bank’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$289	Hold	45	–	–	﹤0.01%	1149
2024 Q4	$362	Hold	45	–	–	﹤0.01%	1144
2024 Q3	$569	Hold	45	–	–	﹤0.01%	1116
2024 Q2	$570	Hold	45	–	–	﹤0.01%	1181
2024 Q1	$216	Hold	45	–	–	﹤0.01%	1188
2023 Q4	$216	Sell	45 -10	-18%	-$61	﹤0.01%	1138
2023 Q3	$399	Hold	55	–	–	﹤0.01%	1130
2023 Q2	$410	Buy	55 +10	+22%	+$79	﹤0.01%	1162
2023 Q1	$312	Hold	45	–	–	﹤0.01%	1116
2022 Q4	$463	Sell	45 -100	-69%	-$1.76K	﹤0.01%	1089
2022 Q3	$3K	Hold	145	–	–	﹤0.01%	1002
2022 Q2	$8K	Hold	145	–	–	﹤0.01%	875
2022 Q1	$11K	Hold	145	–	–	﹤0.01%	839
2021 Q4	$21K	Buy	145 +100	+222%	+$17.2K	﹤0.01%	759
2021 Q3	$9K	Hold	45	–	–	﹤0.01%	898
2021 Q2	$10K	Hold	45	–	–	﹤0.01%	900
2021 Q1	$8K	Sell	45 -30	-40%	-$5.98K	﹤0.01%	826
2020 Q4	$8K	Buy	+75	New	+$7.97K	﹤0.01%	780

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sandy Spring Bank's NVAX Position: Q1 2025 in Review

Sandy Spring Bank held its Novavax (NVAX) position steady in Q1 2025 at 45 shares worth $289. The position accounts for ﹤0.01% of the portfolio, ranked #1149.

Sandy Spring Bank first reported a position in NVAX in Q4 2020 and has held it in 18 quarters since. The position peaked at $21K in Q4 2021. 245 funds tracked by Wall St. Rank hold NVAX as of Q1 2025.

Sandy Spring Bank held 45 shares of Novavax worth $289 as of Q1 2025.
Sandy Spring Bank left its Novavax share count unchanged in Q1 2025.
Novavax made up ﹤0.01% of Sandy Spring Bank's portfolio in Q1 2025, its #1149 holding.
Sandy Spring Bank first reported a position in Novavax in Q4 2020 and has held it in 18 quarters since.
Sandy Spring Bank's Novavax position peaked at $21K in Q4 2021.
245 funds tracked by Wall St. Rank held Novavax as of Q1 2025.

Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.